For the best experience, please enable JavaScript in your browser settings. Wearing your protective style for too long actually damages your hair (Shutterstock ...

Please provide your email address to receive an email when new articles are posted on . Upadacitinib is an oral JAK inhibitor under investigation for the treatment of multiple dermatologic indications ...

Researchers examined the impact of baricitinib withdrawal and retreatment on hair regrowth in patients with severe alopecia areata. Although baricitinib has demonstrated efficacy for treating patients ...

A survey study found a strong association between severe alopecia areata (AA) and significant impairments in quality of life and mental wellbeing, highlighting the need for comprehensive treatment ...

In a study, nearly half of patients with severe alopecia areata (AA) achieved clinically meaningful hair regrowth after switching to a second JAKi, with higher odds among those who had responded to ...

For many people, alopecia areata presents as small, well-defined patches of hair loss on the scalp. But for others with severe cases, the unpredictable autoimmune disease can progress to a complete ...

Alopecia areata is an autoimmune skin condition that causes patches of hair loss on your scalp and other parts of your body with hair. Those can include the eyebrows, eyelashes, beard, and elsewhere.

The U.S. FDA has approved Sun Pharmaceutical Industries Ltd.’s Leqselvi (deuruxolitinib), a JAK1 and JAK2 inhibitor for adults with severe alopecia areata, a chronic autoimmune disease. The ...